CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

CERUS CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026

$2.22+0.04 (+1.83%)

Close on Oct 19, 2026

Market cap: $445.25M
P/E (TTM): –
Dividend yield: –

CERUS CORP cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Depreciation & Amortization	1.43	1.86	2.60	2.98	3.15	3.11	2.40	1.45	1.81	1.82	1.70	1.42	0.75	0.74	0.92	0.85	0.87
Stock-Based Compensation	23	23	20	24	24	18	13	10	9.36	8.07	6.73	5.15	3.27	2.54	1.85	1.83	2.05
Deferred Income Taxes	–	–	–	–	–	–	–	0.00	-0.12	0.03	0.01	0.03	0.03	0.06	0	0	–
Other Non-Cash Items	–	–	–	–	–	–	–	–	–	–	-0.51	-0.13	0.03	-0.02	-0.01	–	–
Change in Accounts Receivable	-0.40	5.50	-1.10	-9.20	-4.22	-4.13	-8.08	3.66	-5.55	-1.07	-0.30	0.63	-1.68	1.65	-1.30	-1.17	0.70
Change in Inventory	-15	7.03	-15	-1.77	-20	-4.03	-6.04	0.81	-2.09	-1.78	3.99	3.03	-1.81	-3.74	-0.60	2.07	3.40
Change in Accounts Payable	5.73	-1.48	-7.34	-4.91	12	1.98	4.94	5.68	2.49	3.26	-3.87	-0.97	-1.51	2.51	1.45	-1.19	0.10
Change in Unearned Revenue	-0.12	-0.60	1.41	-0.08	0.10	0.01	0.07	0.04	0.27	-0.45	0.19	0.27	0.10	-0.03	-0.14	-0.10	-0.10
Operating Cash Flow	4.84	11	-43	-26	-34	-42	-65	-31	-52	-54	-51	-40	-27	-14	-16	-14	-15
Capital Expenditures	-3.73	-2.84	-4.60	-2.00	-0.91	-1.62	-8.94	-1.14	-0.35	-0.56	-0.72	-2.11	-0.66	-0.08	-0.16	-1.69	-0.19
Sale of Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	–	0.03	–	–	–	–	–
Purchase of Investments	-43	-43	-2.49	-30	-52	-99	-44	-81	-69	-83	-90	-26	-30	0	0	0	-0.50
Sale & Maturity of Investments	40	38	16	40	66	51	81	38	70	63	93	25	1.63	0.29	0.67	1.63	9.98
Other Investing Activities	–	–	–	–	–	–	–	–	–	–	–	–	-0.02	0.00	0.06	-0.01	0.04
Investing Cash Flow	-6.17	-8.13	8.62	8.46	13	-50	28	-44	0.42	-20	1.52	-3.15	-29	0.21	0.56	-0.07	9.32
Stock Issued	-0.04	-0.14	-0.18	-0.10	2.74	77	27	85	30	22	75	18	61	14	9.27	19	12
Debt Issued	–	–	–	–	15	–	39	–	30	–	10	9.85	3.10	1.81	–	–	–
Debt Repaid	–	–	–	–	–	–	-31	-0.13	-20	-0.62	-0.11	-3.47	-7.57	-1.46	–	–	–
Financing Cash Flow	0.23	4.96	11	4.19	34	92	43	93	43	25	98	36	59	15	12	26	12
Foreign Exchange Rate Adjustments	0.34	-0.19	-0.13	-0.73	-0.92	1.07	-0.34	–	–	–	–	–	–	–	–	–	–
Net Change in Cash	-0.76	8.00	-24	-14	12	1.48	5.83	18	-8.81	-49	48	-6.70	2.79	1.20	-3.45	12	6.98
Free Cash Flow	1.11	8.52	-48	-28	-35	-43	-74	-32	-53	-54	-52	-42	-27	-14	-16	-16	-15
Income Taxes Paid	0.30	0.36	0.32	0.27	0.28	0.27	0.23	0.25	0.16	0.16	0.15	0.18	0.15	0.16	0.13	0.11	–
Interest Paid	8.52	9.30	9.21	5.10	4.18	3.27	3.08	2.73	2.03	1.37	1.09	0.56	0.29	0.46	1.02	0.60	0.00

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: –
Operating margin: -0.7%
Net margin: -2.9%
Return on equity, FY2025: -26.0%

Financial strength

Current ratio: 1.83
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 21.0%

Valuation

P/E ratio: –
Price to sales: 1.90
Price to book: 6.36
Dividend yield: –